The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
A large real-world study from Cleveland Clinic reveals mixed outcomes after GLP-1 discontinuation: 55% of obese patients regained weight, while 45% maintained or continued losing. Many switched to alternative treatments, highlighting the need for ongoing obesity care. This data underscores gaps in long-term management and the role of nutritional support.
Chronic kidney disease affects over one in seven Americans, but new drugs like Ozempic are changing the game. GLP-1 receptor agonists, SGLT2 inhibitors, and finerenone offer additive benefits beyond traditional RAS inhibitors, potentially halting or reversing progression. Experts like Maarten Taal hail them as game-changers for kidney health.
Zydus Lifesciences and Lupin are teaming up to bring Semaglutide injection to India, positioning it as a rival to Ozempic for type 2 diabetes and chronic weight management. Marketed by Zydus with a user-friendly reusable pen, this GLP-1 therapy offers new options for adults with poor glycemic control or obesity-related conditions. Here's what patients need to know about this launch.
At the Oscars 2026 red carpet, an overwhelming uniformity of extremely slender bodies and sunken cheeks dominated, raising questions about Ozempic and GLP-1 agonists. Celebrities like Demi Moore, Emma Stone, and Oprah Winfrey appeared dramatically thinner, contrasting the body positivity era. Is Hollywood reverting to 'heroin chic' aesthetics?
Side-by-side photos of Vanessa Williams highlight her 'Ozempic face' transformation, marked by wrinkles and an 'Ozempic neck' after using Mounjaro for menopause-related weight gain. The first Black Miss America calls it a 'game-changer' at age 60. A plastic surgeon details how GLP-1 drugs affect facial fat and skin health.
Kelly Osbourne's black sequined mini dress at the BRIT Awards turned heads for more than fashion—her slimmer frame ignited Ozempic speculation. Joined by Demi Moore, Emma Stone, and others at 2026 red carpets, these stars' dramatic weight loss sparked debates on 'Ozempic face' and Hollywood beauty standards. Discover the details and medical context.
Revolutionary GLP-1 medications like Ozempic are helping millions shed pounds quickly, but a new study shows significant muscle loss is a downside. Experts warn that up to 40% of weight lost can be lean tissue, especially with rapid drops. Here's how to protect your muscle while benefiting from these drugs.
Social media buzz highlights itchy skin as a surprising side effect of GLP-1 medications like semaglutide (Ozempic, Wegovy). Patients report hives and mosquito-like bites after doses. Dermatologists and weight loss experts break down causes from allergies to rapid weight loss and offer practical advice.
India's GLP-1 and weight-loss drug market is set for explosive growth, expanding fivefold to ₹5,000 crore by 2030, according to CareEdge Ratings. Semaglutide's patent expiry will trigger sharp price cuts, boosting access amid surging demand from type 2 diabetes patients. However, generic makers face patent battles, manufacturing hurdles, and safety scrutiny.
